Multimodality Imaging of Tumour Thrombus

Saurabh Rohatgi; Stephanie A Howard; Sree Harsha Tirumani; Nikhil H Ramaiya; Katherine M Krajewski

doi:10.1016/j.carj.2014.11.001

Multimodality Imaging of Tumour Thrombus

Can Assoc Radiol J. 2015 May;66(2):121-9. doi: 10.1016/j.carj.2014.11.001. Epub 2015 Feb 3.

Authors

Saurabh Rohatgi¹, Stephanie A Howard¹, Sree Harsha Tirumani², Nikhil H Ramaiya¹, Katherine M Krajewski¹

Affiliations

¹ Department of Imaging, Dana Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Department of Imaging, Dana Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: sreeharsha_tirumani@dfci.harvard.edu.

PMID: 25660299
DOI: 10.1016/j.carj.2014.11.001

Abstract

Vascular thrombosis occurs commonly in cancer patients. Once the diagnosis of thrombosis is established, it is important to characterize the nature of thrombus, tumoural versus bland, as each have a different prognosis, clinical significance, and management. This review paper discusses the imaging spectrum of tumour thrombus and its clinical significance emphasizing the role of imaging in differentiating tumour from bland thrombus.

Keywords: Bland thrombus; Imaging; Thrombus; Tumoural thrombus.

Publication types

Review

MeSH terms

Diagnosis, Differential
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Multimodal Imaging*
Neoplasm Invasiveness
Neoplasms / pathology*
Neoplasms / therapy
Phlebography
Positron-Emission Tomography
Radiopharmaceuticals
Thrombosis / diagnosis*
Thrombosis / therapy
Tomography, X-Ray Computed
Ultrasonography, Doppler, Color
Veins / diagnostic imaging
Veins / pathology

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18